Literature DB >> 17189472

Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.

Peter J Stogios1, Lu Chen, Gilbert G Privé.   

Abstract

BTB-zinc finger (BTB-ZF) proteins are transcription regulators with roles in development, differentiation, and oncogenesis. In these proteins, the BTB domain (also known as the POZ domain) is a protein-protein interaction motif that contains a dimerization interface, a possible oligomerization surface, and surfaces for interactions with other factors, including nuclear co-repressors and histone deacetylases. The BTB-ZF protein LRF (also known as ZBTB7, FBI-1, OCZF, and Pokemon) is a master regulator of oncogenesis, and represses the transcription of a variety of important genes, including the ARF, c-fos, and c-myc oncogenes and extracellular matrix genes. We determined the crystal structure of the BTB domain from human LRF to 2.1 A and observed the canonical BTB homodimer fold. However, novel features are apparent on the surface of the homodimer, including differences in the lateral groove and charged pocket regions. The residues that line the lateral groove have little similarity with the equivalent residues from the BCL6 BTB domain, and we show that the 17-residue BCL6 Binding Domain (BBD) from the SMRT co-repressor does not bind to the LRF BTB domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189472      PMCID: PMC2203294          DOI: 10.1110/ps.062660907

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

1.  FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.

Authors:  P Shannon Pendergrast; Chen Wang; Nouria Hernandez; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

Review 2.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

3.  In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Authors:  A Melnick; K F Ahmad; S Arai; A Polinger; H Ball; K L Borden; G W Carlile; G G Prive; J D Licht
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  GRASP2: visualization, surface properties, and electrostatics of macromolecular structures and sequences.

Authors:  Donald Petrey; Barry Honig
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

5.  N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso.

Authors:  Ho-Geun Yoon; Doug W Chan; Albert B Reynolds; Jun Qin; Jiemin Wong
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

6.  SuperPose: a simple server for sophisticated structural superposition.

Authors:  Rajarshi Maiti; Gary H Van Domselaar; Haiyan Zhang; David S Wishart
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

7.  Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.

Authors:  X Li; J M Lopez-Guisa; N Ninan; E J Weiner; F J Rauscher; R Marmorstein
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

Review 8.  The transcription factor Pokemon: a new key player in cancer pathogenesis.

Authors:  Takahiro Maeda; Robin M Hobbs; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

9.  Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.

Authors:  Jose M Polo; Tania Dell'Oso; Stella Maris Ranuncolo; Leandro Cerchietti; David Beck; Gustavo F Da Silva; Gilbert G Prive; Jonathan D Licht; Ari Melnick
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

10.  FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB.

Authors:  Dong-Kee Lee; Jae-Eun Kang; Hye-Jin Park; Myung-Hwa Kim; Tae-Hee Yim; Jung-Min Kim; Min-Kyu Heo; Kyu-Yeun Kim; Ho Jeong Kwon; Man-Wook Hur
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

View more
  23 in total

Review 1.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

2.  Structure of the wild-type human BCL6 POZ domain.

Authors:  Mark A Stead; Gareth O Rosbrook; Jonathan M Hadden; Chi H Trinh; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-11-28

3.  Structure of the human Nac1 POZ domain.

Authors:  Mark A Stead; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-04-24

4.  The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder.

Authors:  Changcheng Guo; Dabo Xiong; Bin Yang; Haiming Zhang; Wenyu Gu; Min Liu; Xudong Yao; Junhua Zheng; Bo Peng
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

5.  Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.

Authors:  Anshu Aggarwal; William J Hunter; Himanshu Aggarwal; Edibaldo D Silva; Mary S Davey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-21       Impact factor: 3.362

6.  Structural-functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression.

Authors:  Ke Zhang; Guijun Shang; Abhilash Padavannil; Juan Wang; Ramanavelan Sakthivel; Xiang Chen; Min Kim; Matthew G Thompson; Adolfo García-Sastre; Kristen W Lynch; Zhijian J Chen; Yuh Min Chook; Beatriz M A Fontoura
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-11       Impact factor: 11.205

7.  Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains.

Authors:  Toshihiko Ogura; Kit I Tong; Kazuhiro Mio; Yuusuke Maruyama; Hirofumi Kurokawa; Chikara Sato; Masayuki Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

8.  Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1.

Authors:  Mark Alexander Stead; Stephanie Claire Wright
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

9.  A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.

Authors:  Leandro C Cerchietti; Alexandru F Ghetu; Xiao Zhu; Gustavo F Da Silva; Shijun Zhong; Marilyn Matthews; Karen L Bunting; Jose M Polo; Christophe Farès; Cheryl H Arrowsmith; Shao Ning Yang; Monica Garcia; Andrew Coop; Alexander D Mackerell; Gilbert G Privé; Ari Melnick
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

Review 10.  Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.

Authors:  Samir Parekh; Gilbert Privé; Ari Melnick
Journal:  Leuk Lymphoma       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.